Close Menu

NEW YORK (GenomeWeb) – Danaher's proposed $4 billion acquisition of Cepheid has cleared antitrust requirements, Cepheid announced today.

Specifically, the firm said antitrust clearances have been received or the required waiting periods have expired in the US, Germany, Austria, and South Africa. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.